Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)

This publication has 51 references indexed in Scilit:

• Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype
  Blood, 2002
• Absence of Interaction of Fondaparinux Sodium with Aspirin and Piroxicam in Healthy Male Volunteers
  Clinical Pharmacokinetics, 2002
• The Pharmacokinetics of Fondaparinux Sodium in Healthy Volunteers
  Clinical Pharmacokinetics, 2002
• The Conformational Activation of Antithrombin: A 2.85-Å STRUCTURE OF A FLUORESCEIN DERIVATIVE REVEALS AN ELECTROSTATIC LINK BETWEEN THE HINGE AND HEPARIN BINDING REGIONS
  Published by Elsevier ,2000
• Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia
  Blood Coagulation & Fibrinolysis, 1997
• SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent
  Cardiovascular Drug Reviews, 1997
• Mechanism of Heparin Activation of Antithrombin. Evidence for Reactive Center Loop Preinsertion with Expulsion upon Heparin Binding
  Biochemistry, 1996
• Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of Heparin
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit
  British Journal of Haematology, 1990
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
  New England Journal of Medicine, 1988